NDRI Awarded $7.6 Million Grant From NIH For the Next Five Years ... PR-Inside.com (Pressemitteilung), Austria - Nov 8, 2008 This funding will help sustain and enhance NDRI's efforts to provide the many investigators who depend on tissue/cell samples from us with the highest ...
Newspapers Examine Possible HIV/AIDS Treatment Through Bone Marrow ... Medical News Today (press release), UK - Nov 17, 2008 Anthony Fauci, director of NIH's National Institute of Allergy and Infectious Diseases, said the treatment is "very nice" and "not even surprising," but ...
Organizational Improvements to Enhance Modern Clinical Epidemiology Journal of American Medical Association (subscription), IL - Nov 18, 2008 By discerning structure in patterns of gene, protein, or metabolite expression that provide snapshots of gene activity in a cell or tissue sample, ...
Source: Google News
Recent News and Articles on the Keywords: nih + hearing + house Related to the article below (Last Update: 8/5/2008)
Providence firm wins NIH grant Providence Journal, RI - Jul 8, 2008 ?Green jobs? bill to get hearing in Mass. Massachusetts lawmakers are planning a hearing on a bill designed to increase the number of so-called ?green jobs? ...
Dexter's Meurer answers his calling Dexter Leader, MI - Jul 23, 2008 "Liam has grown to love hearing the trains go by and runs to the window to see them." Liz has been active in the Dexter Community Players. ...
The Dearness of Life American Spectator - Jul 13, 2008 It went through NIH trials and has been approved and paid for by Medicare since 2004. Dr. Jordan and his co-inventor, Dolly Tyan who is now at Stanford ...
Source: Google News
Prognostic factors for hearing preservation in vestibular schwannoma surgery. - … , A De la Cruz, JW House, RA Nelson, WM Luxford, … - Am J Otol, 2000 - ncbi.nlm.nih.gov ... and House Ear Institute, Clinical Studies Department, Los Angeles, California 90057,
USA. OBJECTIVE: To determine whether prognostic indicators for hearing...
Hearing preservation after acoustic tumor removal: long-term results. - C Shelton, WE Hitselberger, WF House, DE Brackmann - Laryngoscope, 1990 - ncbi.nlm.nih.gov 1990 Feb;100(2 Pt 1):115-9. Hearing preservation after acoustic tumor removal:
long-term results. Shelton C, Hitselberger WE, House WF, Brackmann DE. ...
Hearing by cochlear nucleus stimulation in humans. BJ Edgerton, WF House, W Hitselberger - Ann Otol Rhinol Laryngol Suppl, 1982 - ncbi.nlm.nih.gov Hearing by cochlear nucleus stimulation in humans. Edgerton BJ, House WF,
Hitselberger W. Publication Types: Case Reports. MeSH Terms: ...
Calcitonin as treatment for hearing loss in Paget's disease. - M el Sammaa, FH Linthicum Jr, HP House, JW House - Am J Otol, 1986 - ncbi.nlm.nih.gov ... el Sammaa M, Linthicum FH Jr, House HP, House JW. Progressive hearing loss is a
potential complication of Paget's disease, a metabolic disorder of accelerated ...
Hearing improvement after acoustic tumor removal. C Shelton, WF House - Otolaryngol Head Neck Surg, 1990 - ncbi.nlm.nih.gov 1990 Dec;103(6):963-5. Hearing improvement after acoustic tumor removal. Shelton
C, House WF. Otologic Medical Group, Inc., Los Angeles, California. ...
Source: Google Scholar
NIH Statement Regarding House Hearing on Human Tissue Samples
Attribution: John Burklow, NIH spokesman
NIH’s position on ethics is clear: any conflict of interest resulting in an individual personally profiting from official government research activities cannot be tolerated. We are committed to maintaining the public’s trust in NIH and its scientists as an unbiased source of biomedical research guidance and advice. The case under consideration concerns events that began in 1998 — after the NIH ethics rules concerning outside activities were relaxed — and that ended before the new rules were put in place. NIH has previously referred this case to the relevant authorities for appropriate action.
It is important to note that the specific consulting arrangements in question, had they been known to NIH, would not have been approved under the present or previous ethics regulations. Outside consulting connected to an NIH employee’s official government duties has always been prohibited at NIH.
NIH has undertaken a comprehensive review of its activities and conflict of interest policies in the last few years. As a result of that process, on August 25, 2005, NIH implemented comprehensive ethics rules that make it clear what NIH scientists can and cannot do in regard to outside activities. These new rules removed any ambiguity about what is allowed or not allowed. Here are two important points:
Under new NIH regulations, all NIH employees are now prohibited from engaging in outside employment with pharmaceutical companies and biotechnology companies in their private capacities — period.
Collaboration and partnership with industry can nonetheless be very valuable in scientific pursuits and NIH rules allow such activities, as long as they are undertaken through an officially approved Cooperative Research and Development Agreement (CRADA).
Although we cannot discuss this particular case because it remains under investigation, we can speak to the relevant issues that it raises.
Collaborations among scientists that involve human tissue samples are common and essential for science. There are, however, stringent rules in place to protect the participants who donated their samples, and to ensure that there is full informed consent.
We share the Committee’s concerns in regard to the ethical management of human tissue samples and the development of rigorous and uniform policies to protect the public’s trust and interests, while advancing science to address important public health problems. The thousands of scientists who work at NIH have always been and remain committed to these principles.
The Office of the Director, the central office at NIH, is responsible for setting policy for NIH, which includes 27 Institutes and Centers. This involves planning, managing, and coordinating the programs and activities of all NIH components. The Office of the Director also includes program offices which are responsible for stimulating specific areas of research throughout NIH. Additional information is available at http://www.nih.gov/icd/od/.
The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.